GOODWILL AND DEFINITE-LIVED INTANGIBLE ASSETS (Tables)

9 Months Ended

Sep. 30, 2019

GOODWILL AND DEFINITE-LIVED INTANGIBLE ASSETS

Schedule of changes in goodwill by segment

	Specialty		PBM(a)		Total
Balance at January 1, 2019
Goodwill	$	386,436	$	448,122	$	834,558
Accumulated impairment losses		(45,776)		(179,190)		(224,966)
		340,660		268,932		609,592
Goodwill acquired with InTouch acquisition		7,082		—		7,082
Impairment losses (second quarter)		(68,218)		(54,673)		(122,891)
Impairment losses (third quarter)		—		(122,076)		(122,076)
Other		—		(138)		(138)
Balance at September 30, 2019
Goodwill		393,518		447,984		841,502
Accumulated impairment losses		(113,994)		(355,939)		(469,933)
	$	279,524	$	92,045	$	371,569

(a) The goodwill in the PBM segment was recorded as a result of two separately acquired entities (i) Pharmaceutical Technologies, Inc. d/b/a National Pharmaceutical Services, acquired in November 27, 2017, and (ii) LDI Holding Company, LLC, acquired December 20, 2017.

Schedule of definite-lived intangible assets

	September 30, 2019
	Weighted
	Average	Gross				Net
	Amortization	Carrying		Accumulated		Carrying
	Period Remaining	Amount		Amortization		Amount
Customer relationships	9.3	$	52,000	$	—	$	52,000
Patient relationships	5.3		174,500		(81,535)		92,965
Trade names and trademarks	2.7		29,620		(25,171)		4,449
Non-compete employment agreements	1.3		51,659		(45,275)		6,384
Total definite-lived intangible assets		$	307,779	$	(151,981)	$	155,798

	December 31, 2018
	Weighted
	Average	Gross				Net
	Amortization	Carrying		Accumulated		Carrying
	Period Remaining	Amount		Amortization		Amount
Customer relationships	9.8	$	100,200	$	(1,238)	$	98,962
Patient relationships	5.9		170,100		(67,964)		102,136
Trade names and trademarks	1.8		30,650		(20,270)		10,380
Non-compete employment agreements	1.6		61,389		(44,100)		17,289
Physician relationships	4.8		21,700		(9,657)		12,043
Total definite-lived intangible assets		$	384,039	$	(143,229)	$	240,810